top of page
News, Events and Updates
Search
Jan 8, 2020
Anavex Life Sciences Issued New US Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders
Dec 16, 2019
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Update
Dec 10, 2019
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Resultson Monday December 16, 2019
Dec 4, 2019
Anavex Life Sciences Presents ANAVEX®2-73 Data at 12th Clinical Trials on CTAD 2019 Conference
Nov 14, 2019
Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73
Nov 6, 2019
Anavex Life Sciences Announces Publication of Foundational Data for ANAVEX®2-73 in Rett Syndrome
Oct 9, 2019
Anavex Life Sciences Announces ATTENTION-AD ANAVEX®2-73 Extension Study in Early Alzheimer’s Disease
Oct 2, 2019
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX®2-73
Sep 27, 2019
Anavex Life Sciences Presented at the 6th Annual European Rett Syndrome Conference
Sep 26, 2019
Anavex Life Sciences to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2019
Anavex Life Sciences to Present at the Ladenburg Thalmann 2019 Healthcare Conference
15
16
17
18
19
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
